Organon & Co. (OGN)
(Delayed Data from NYSE)
$19.49 USD
-0.69 (-3.42%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $19.50 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
OGN 19.49 -0.69(-3.42%)
Will OGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for OGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OGN
Organon (OGN) Gains But Lags Market: What You Should Know
Organon (OGN) Outperforms Broader Market: What You Need to Know
OGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Is Trending Stock Organon & Co. (OGN) a Buy Now?
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
Other News for OGN
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Eyes on Fed ahead of expected interest rate cut: Morning Buzz
Organon & Co (OGN) Stock Price Down 4.87% on Sep 18
Evercore ISI Sticks to Their Buy Rating for Organon (OGN)
Roivant divestment of Dermavant 'great decision,' says JPMorgan